dihydroartemisinin

dihxdroarteannui dihydroartemisinine dihyroartemisinin 3,12- epoxy-12-pyrano[4,3-j]-1,2-benzodioxepin-10-ol, decahydro-3,6,9-trimethyl-, (5aS,6R,8aS,9R,10S,12R,12aR)- 3,12- epoxy-12H-yrano(4,3-j)-1,2-benzodioxepin-10-ol, decahydro-3,6,9-trimethyl-, (3R,5aS,6R,8aS,9R,10S,12R,12aR)- 3,12- epoxy-12H-yrano[4,3-j]-1,2-benzodioxepin-10-ol, decahydro-3,6,9-trimethyl-, (3R,5aS,6R,8aS,9R,10S,12R,12aR)- 1,5,9- trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol (1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9- trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol (4S,5R,8S,9R,10S,12R,13R)-1,5,9- trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol (3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9- trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-ol (5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9- trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-ol PubMed: Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo-controlled, non-inferiority trial in Kenyan children. PubMed: Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer. PubMed: Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya. PubMed: The Importance of Blood Is Infinite: Conceptions of Blood as Life Force, Rumours and Fear of Trial Participation in a Fulani Village in Rural Gambia. PubMed: Therapeutic effects of dihydroartemisinin and transferrin against glioblastoma. PubMed: Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin. PubMed: Amino acid efflux by asexual blood-stage Plasmodium falciparum and its utility in interrogating the kinetics of hemoglobin endocytosis and catabolism in vivo. PubMed: Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria. PubMed: Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women. PubMed: Pharmacokinetics of a novel sublingual spray formulation of the antimalarial drug artemether in African children with malaria. PubMed: Health & Demographic Surveillance System Profile: The Rufiji Health and Demographic Surveillance System (Rufiji HDSS). PubMed: Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling. PubMed: Embryotoxicity and toxicokinetics of the antimalarial artesunate in rats. PubMed: Advances in nanomedicines for malaria treatment. PubMed: A screening-based approach to circumvent tumor microenvironment-driven intrinsic resistance to BCR-ABL+ inhibitors in Ph+ acute lymphoblastic leukemia. PubMed: Dihydroartemisinin promotes angiogenesis during the early embryonic development of zebrafish. PubMed: Inhibitory effect of dihydroartemisinin against phorbol ester-induced cyclooxygenase-2 expression in macrophages. PubMed: Management of imported malaria in Europe. PubMed: Cleavage mechanism and anti-tumor activity of 3,6-epidioxy-1,10-bisaboladiene isolated from edible wild plants. PubMed: Monitoring of artemisinin, dihydroartemisinin, and artemether in environmental matrices using high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS). PubMed: Malaria: severe, life-threatening. PubMed: Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects. PubMed: Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects. PubMed: Understanding the pharmacokinetics of Coartem. PubMed: Progress in the development of piperaquine combinations for the treatment of malaria. PubMed: Bioavailability of a co-formulated combination of amodiaquine and artesunate under fed and fasted conditions. A randomised, open-label crossover study. PubMed: The influence of food on the pharmacokinetics of piperaquine in healthy Vietnamese volunteers. PubMed: Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PubMed: Artemisinin-based combination therapies for uncomplicated malaria. PubMed: Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects. PubMed: Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues. PubMed: Effects of dihydroartemisinin on fine structure of erythrocytic stages of Plasmodium berghei ANKA strain. PubMed: Arteether toxicokinetics and pharmacokinetics in rats after 25 mg/kg/day single and multiple doses. PubMed: The effect of grapefruit juice on the time-dependent decline of artemether plasma levels in healthy subjects. PubMed: Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. PubMed: Morphologic effects of artemisinin in Plasmodium falciparum.